Features

Who Owns this Joint?

As a result of the vacuum created by the withdrawal of COX-2 inhibitor drugs, fierce competition rages on between the medical and supplement industries, which are both vying for consumers that suffer from various joint ailments.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters